News

International Low-Grade Glioma Patient Registry Low-grade gliomas (LGG), those classified as Grade II by the World Health Organization, are an understudied group of brain tumors that generally strikes patients in the prime of life. They have a lower average age at diagnosis, but fortunately have a better survival prognosis than high-grade gliomas (those classified as Grades III and IV). While […] December 16, 2016

Brain Tumor Research Highlights: November 2016 NOTE: In October, our 2016 NBTS Scientific Summit Recap replaced our typical monthly Brain Tumor Research Highlights. We posted the September Highlights as usual. Over the years, NBTS has given more than $32 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer […] November 15, 2016

Guest Post: Battling Brain Cancers Through Genomics NOTE: This story originally appeared in Mayo Clinic’s Discovery’s Edge magazine. For the better part of a century, brain tumors have been judged by their appearance. Where a tumor was located, how much it spread, and what it looked like under the microscope all determined whether a patient was given a good or bad prognosis, […] October 12, 2016

Brain Tumor Research Highlights: July 2016 > SEE THE JUNE BRAIN TUMOR RESEARCH HIGHLIGHTS Over the years, NBTS has given more than $32 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship research […] July 28, 2016

Research Updates: Recent NBTS-Funded Research The ultimate goal of scientific endeavor in the field of cancer research is to advance discoveries made in the laboratory through the translational and pre-clinical research process to become new medicines patients can take in the clinic. But as scientific discoveries and advancements occur, it is also important that results from studies be published in […] April 20, 2016